Absci ABSI
NASDAQ ABSI
$8.97 +0.16 (+1.87%)
As of: Sep 4, 2026 · 11:50 AM EDT

Absci (ABSI) Operating Income (2020 - 2026)

Absci (ABSI) posted Operating Income of -$30.8 million for Q1 2026, up 0.63% sequentially from -$31.0 million in Q4 2025, and down 11.24% YoY from -$34.8 million in Q1 2025.

Analysis

Absci (ABSI) Operating Income (2020 - 2026) Analysis & Trends

Absci has reported Operating Income for 7 years, with the latest figure at -$30.8 million in Q1 2026.

  • Quarterly Operating Income fell 11.24% year-over-year to -$30.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$123.4 million (down 9.12% YoY) and the FY2025 annual result came in at -$120.3 million, down 10.5% from the prior year.
  • Operating Income grew to -$30.8 million in Q1 2026 per ABSI's latest filing, from -$31.0 million in the prior quarter.
  • Over five years, Operating Income peaked at -$21.1 million in Q4 2022 and troughed at -$43.0 million in Q2 2023.
  • A 5-year average of -$28.4 million and a median of -$28.8 million in 2022 frame the typical range for Operating Income.
  • The sharpest annual moves came in 2022 and 2024: Operating Income tumbled 158.37% in 2022, then surged 37.84% in 2024.
  • Over 5 years, Operating Income stood at -$21.1 million in 2022, then decreased by 17.29% to -$24.7 million in 2023, then retreated by 20.35% to -$29.8 million in 2024, then declined by 4.26% to -$31.0 million in 2025, then grew by 0.63% to -$30.8 million in 2026.
  • According to Business Quant data, Operating Income over the past three periods registered -$30.8 million, -$31.0 million, and -$30.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Vertex Pharmaceuticals 140.22 Bn 132.37 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 86.04 Bn 78.05 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 63.70 Bn 58.52 Bn 1.37 Bn 493.00 Mn
4 Moderna 57.56 Bn 52.42 Bn 52.00 Mn -815.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - -505.13 Mn
6 BeOne Medicines 40.16 Bn 35.06 Bn 1.53 Bn 325.05 Mn
7 Alnylam Pharmaceuticals 35.63 Bn 32.32 Bn 992.69 Mn 231.44 Mn
8 Royalty Pharma 28.63 Bn 27.79 Bn - 133.12 Mn
9 Insmed 27.73 Bn 26.57 Bn 358.27 Mn -1.55 Mn
10 Absci 1.41 Bn 1.21 Bn - -34.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -34.16 Mn
Mar 31, 2026 -30.85 Mn
Dec 31, 2025 -31.04 Mn
Sep 30, 2025 -30.15 Mn
Jun 30, 2025 -31.39 Mn
Mar 31, 2025 -27.73 Mn
Dec 31, 2024 -29.77 Mn
Sep 30, 2024 -28.90 Mn
Jun 30, 2024 -26.72 Mn
Mar 31, 2024 -23.50 Mn
Dec 31, 2023 -24.74 Mn
Sep 30, 2023 -23.30 Mn
Jun 30, 2023 -42.99 Mn
Mar 31, 2023 -24.49 Mn
Dec 31, 2022 -21.09 Mn
Sep 30, 2022 -27.97 Mn
Jun 30, 2022 -28.89 Mn
Mar 31, 2022 -28.80 Mn
Dec 31, 2021 -26.26 Mn
Sep 30, 2021 -21.14 Mn